Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRACLE: Balcinrenone + Dapagliflozin in HF and CKD
NCT04595370Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 22
01
Overview
A Phase 2 trial of balcinrenone in heart failure (HF), chronic kidney disease (CKD), sponsored by AstraZeneca. Started Jan 2021; status: completed.
02
Drugs
balcinrenone
03
Conditions
heart failure (HF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT04595370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04595370.